id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-E-0073-0005,FDA,FDA-1998-E-0073,Determination of Regulatory Review Period for Purposes of Patent Extension; Vitreon,Notice,General Notice,1998-12-21T05:00:00Z,1998,12,1998-12-21T05:00:00Z,1999-07-16T03:59:59Z,2025-03-05T18:10:58Z,98-33457,0,0,0900006480583e30
FDA-1998-N-0026-0001,FDA,FDA-1998-N-0026,FDA,Notice,"NRD-Notice of Requesting Data, Info, & Views",1998-12-15T05:00:00Z,1998,12,,,2008-05-16T21:28:54Z,,0,0,09000064805648ac
FDA-1984-G-0001-0001,FDA,FDA-1984-G-0001,American Feed Industry Association; Withdrawal of Generally Recognized As Safe (GRAS) Petition - Notice of Withdrawl,Notice,NWL-Notice of Withdrawl,1998-12-09T05:00:00Z,1998,12,,,2014-07-17T17:24:14Z,,0,0,09000064805a7533
FDA-1997-C-0043-0001,FDA,FDA-1997-C-0043,Closure Medical Corp.; Withdrawal of Color Additive Petition,Notice,Withdrawal,1998-12-07T05:00:00Z,1998,12,,,2024-11-06T13:59:15Z,,0,0,09000064805cfc65
FDA-1998-N-0006-0005,FDA,FDA-1998-N-0006,HF-7,Notice,NFR-Notice of Final Rule,1998-11-19T05:00:00Z,1998,11,,,2008-05-16T21:28:34Z,,0,0,0900006480558a70
FDA-1998-D-0097-0001,FDA,FDA-1998-D-0097,"Guidance for Industry on Fast Track Drug Development Programs: Designation, Development, and Application Review; Availability; Collection of Information",Notice,NAD-Notice of Availability of Data,1998-11-19T05:00:00Z,1998,11,1998-11-19T05:00:00Z,1999-02-17T04:59:59Z,2008-11-19T00:03:09Z,,0,0,0900006480586ae6
FDA-1998-N-0049-0001,FDA,FDA-1998-N-0049,Medical Devices; Revocation of Exemptions from Premarket Notification for Certain Cardiovascular and Physical Medicine Devices,Notice,Withdrawal,1998-11-19T05:00:00Z,1998,11,1998-11-19T05:00:00Z,1999-01-27T04:59:59Z,2026-01-23T22:34:42Z,,0,0,090000648056e79c
FDA-1996-N-0018-0001,FDA,FDA-1996-N-0018,Agency Information Collection Activities; Proposed Collection; MedWatch: The FDA Medical Products Reporting Program; Comment Request A.G,Notice,General Notice,1998-11-13T05:00:00Z,1998,11,1998-11-13T05:00:00Z,1999-01-12T04:59:59Z,2024-09-12T15:07:50Z,,0,0,09000064804fa4f3
FDA-1998-D-0002-0001,FDA,FDA-1998-D-0002,FDA,Notice,NAD-Notice of Availability of Data,1998-11-06T05:00:00Z,1998,11,1998-11-06T05:00:00Z,1999-02-04T04:59:59Z,2008-05-16T21:17:54Z,,0,0,0900006480558677
FDA-1998-D-0039-0003,FDA,FDA-1998-D-0039,FDA,Notice,NAD-Notice of Availability of Data,1998-11-06T05:00:00Z,1998,11,,,2008-05-16T21:23:02Z,,0,0,090000648056e4fd
FDA-1998-N-0027-0001,FDA,FDA-1998-N-0027,Electronic Reporting of Postmarketing Adverse Drug Reactions; Request for Comments,Notice,Proposed Guidelines,1998-11-06T05:00:00Z,1998,11,1998-11-05T05:00:00Z,1999-02-04T04:59:59Z,2024-11-18T16:45:45Z,98-29564,0,0,0900006480564ac8
FDA-1976-N-0520-0011,FDA,FDA-1976-N-0520,Eli Lilly & Co. and Bristol-Myers Squibb Co.; Withdrawal of Approval of Three New Drug Applications for Estrogen-Androgen Combination Drugs,Notice,NWL-Notice of Withdrawl,1998-11-04T05:00:00Z,1998,11,,,2018-08-02T16:31:49Z,,0,0,090000648053be5b
FDA-1976-N-0520-0010,FDA,FDA-1976-N-0520,"Eli Lilly & Co. and Bristol-Myers Squibb Co.; Withdrawal of Approval of
Three New Drug Applications for Estrogen-Androgen Combination Drugs",Notice,Withdrawal,1998-11-04T05:00:00Z,1998,11,,,2018-08-02T16:31:12Z,98-29049,0,0,090000648053be5a
FDA-1997-D-0009-0002,FDA,FDA-1997-D-0009,FDA,Notice,NAD-Notice of Availability of Data,1998-10-21T04:00:00Z,1998,10,,,2008-05-16T21:59:17Z,,0,0,09000064805c9a37
FDA-1998-D-0021-0001,FDA,FDA-1998-D-0021,FDA,Notice,NEC-Notice of Extension,1998-10-20T04:00:00Z,1998,10,1998-10-20T04:00:00Z,1998-11-24T04:59:59Z,2008-05-16T21:18:01Z,,0,0,0900006480564036
FDA-1998-N-0068-0005,FDA,FDA-1998-N-0068,HFM-17,Notice,NEC-Notice of Extension,1998-10-20T04:00:00Z,1998,10,1998-10-20T04:00:00Z,1998-11-17T04:59:59Z,2008-05-16T21:31:26Z,,0,0,0900006480571d21
FDA-1998-D-0035-0001,FDA,FDA-1998-D-0035,FDA,Notice,NAD-Notice of Availability of Data,1998-10-20T04:00:00Z,1998,10,1998-10-20T04:00:00Z,1998-12-15T04:59:59Z,2008-05-16T21:18:11Z,,0,0,09000064805657a0
FDA-1998-N-0068-0004,FDA,FDA-1998-N-0068,HFM-17,Notice,NEC-Notice of Extension,1998-10-20T04:00:00Z,1998,10,1998-10-20T04:00:00Z,1998-11-17T04:59:59Z,2008-05-16T21:31:25Z,,0,0,0900006480571d20
FDA-1998-N-0070-0001,FDA,FDA-1998-N-0070,"Privacy Act of 1974; Altered System of Records, Including Addition of Routine Use(s) to an Existing System of Records",Notice,Privacy Act,1998-10-20T04:00:00Z,1998,10,1998-10-19T04:00:00Z,1998-11-19T04:59:59Z,2024-09-30T18:10:52Z,98–27937,0,0,0900006480571de0
FDA-1998-N-0068-0006,FDA,FDA-1998-N-0068,HFM-17,Notice,NEC-Notice of Extension,1998-10-20T04:00:00Z,1998,10,1998-10-20T04:00:00Z,1998-11-17T04:59:59Z,2008-05-16T21:31:25Z,,0,0,0900006480571d22
FDA-1998-N-0107-0002,FDA,FDA-1998-N-0107,Medical Devices; 30-Day Notices and 135-Day PMA Supplement Review,Notice,Notice of Final Rule,1998-10-09T04:00:00Z,1998,10,,,2024-08-21T14:50:19Z,,0,0,0900006480587ef2
FDA-1998-N-0053-0001,FDA,FDA-1998-N-0053,FDA,Notice,NPR-Notice of Proposed Rule-Making,1998-10-09T04:00:00Z,1998,10,1998-10-09T04:00:00Z,1998-11-24T04:59:59Z,2008-05-16T21:29:13Z,,0,0,090000648056ea01
FDA-1993-C-0016-0002,FDA,FDA-1993-C-0016,Listing of Color Additives Exempt from Certification; Canthaxanthin; Confirmation of Effective Date; Correction,Notice,Notice of Confirmation of Effective Date,1998-10-02T04:00:00Z,1998,10,,,2024-04-25T17:43:21Z,98-25640,0,0,09000064804fa730
FDA-1984-D-0009-0001,FDA,FDA-1984-D-0009,FDA,Notice,N-Notice,1998-09-28T04:00:00Z,1998,9,,,2008-05-30T22:53:25Z,,0,0,09000064805a77e7
FDA-1998-N-0006-0004,FDA,FDA-1998-N-0006,HF-27,Notice,NCR-Notice of Correction,1998-09-24T04:00:00Z,1998,9,,,2008-05-16T21:28:34Z,,0,0,0900006480558a6f
FDA-1998-N-0006-0003,FDA,FDA-1998-N-0006,HF-7,Notice,NWL-Notice of Withdrawl,1998-09-24T04:00:00Z,1998,9,,,2008-05-16T21:28:34Z,,0,0,0900006480558a6e
FDA-1998-D-0100-0001,FDA,FDA-1998-D-0100,FDA,Notice,NAD-Notice of Availability of Data,1998-09-24T04:00:00Z,1998,9,1998-09-24T04:00:00Z,1998-11-24T04:59:59Z,2008-05-16T21:23:21Z,,0,0,090000648058708a
FDA-1998-D-0102-0003,FDA,FDA-1998-D-0102,FDA,Notice,NCR-Notice of Correction,1998-09-14T04:00:00Z,1998,9,,,2008-05-16T21:23:24Z,,0,0,090000648058738c
FDA-1981-N-0043-0006,FDA,FDA-1981-N-0043,Pediculicide Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment; Correction,Notice,Correction,1998-09-09T04:00:00Z,1998,9,,,2021-03-15T13:27:27Z,98-23400,0,0,09000064805af2f7
FDA-1998-N-0041-0003,FDA,FDA-1998-N-0041,Biological Products Regulated Under Section 351 of the Public Health Services Act; implementation of Biologics License; Elimination of Establishment License and Product License; Correction,Notice,Correction,1998-09-04T04:00:00Z,1998,9,,,2026-01-30T03:45:33Z,98-23586,0,0,090000648056e5a6
FDA-1998-D-0052-0002,FDA,FDA-1998-D-0052,FDA,Notice,NEC-Notice of Extension,1998-08-27T04:00:00Z,1998,8,1998-08-27T04:00:00Z,1998-11-25T04:59:59Z,2008-05-16T21:23:07Z,,0,0,090000648056e979
FDA-1998-N-0029-0001,FDA,FDA-1998-N-0029,Medical Device Warning Letter Pilot Termination,Notice,General Notice,1998-08-27T04:00:00Z,1998,8,,,2024-11-14T20:53:05Z,03-3436,0,0,0900006480564dae
FDA-1998-N-0071-0002,FDA,FDA-1998-N-0071,Regulations on Statements made for Dietary Supplements Concerning the Effects of the Products on the Structure or Function of the Body; Extension of Comment Period,Notice,NEC-Notice of Extension,1998-08-27T04:00:00Z,1998,8,1998-08-27T04:00:00Z,1998-09-29T03:59:59Z,2008-07-23T23:37:30Z,,0,0,09000064805730ad
FDA-1998-N-0103-0003,FDA,FDA-1998-N-0103,FDA,Notice,NM-Notice of Meeting,1998-08-20T04:00:00Z,1998,8,,,2008-05-16T21:37:58Z,,0,0,090000648058750a
FDA-1998-N-0103-0004,FDA,FDA-1998-N-0103,FDA,Notice,NM-Notice of Meeting,1998-08-20T04:00:00Z,1998,8,,,2008-05-16T21:37:58Z,,0,0,090000648058750c
FDA-1998-N-0041-0002,FDA,FDA-1998-N-0041,Biological Products Regulated Under Section 351 of the Public Health Services Act; implementation of Biologics License; Elimination of Establishment License and Product License; Public Workshop,Notice,Public Meetings,1998-08-19T04:00:00Z,1998,8,1998-08-19T04:00:00Z,1998-10-15T03:59:59Z,2026-01-30T03:45:58Z,98-21406,0,0,090000648056e59a
FDA-1981-N-0043-0005,FDA,FDA-1981-N-0043,Pediculicide Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment,Notice,Notice of Final Rule,1998-08-14T04:00:00Z,1998,8,,,2021-03-15T13:13:26Z,98-21794,0,0,09000064805af2f6
FDA-1998-N-0068-0003,FDA,FDA-1998-N-0068,FDA,Notice,NEC-Notice of Extension,1998-08-03T04:00:00Z,1998,8,1998-08-03T04:00:00Z,1998-10-16T03:59:59Z,2008-05-16T21:31:26Z,,0,0,0900006480571d19
FDA-1998-N-0068-0002,FDA,FDA-1998-N-0068,FDA,Notice,NEC-Notice of Extension,1998-08-03T04:00:00Z,1998,8,1998-08-03T04:00:00Z,1998-10-16T03:59:59Z,2008-05-16T21:31:26Z,,0,0,0900006480571d18
FDA-1998-N-0041-0001,FDA,FDA-1998-N-0041,Biological Products Regulated Under Section 351 of the Public Health Services Act; implementation of Biologics License; Elimination of Establishment License and Product License,Notice,Proposed Guidelines,1998-08-03T04:00:00Z,1998,8,1998-08-03T04:00:00Z,1998-10-15T03:59:59Z,2026-01-30T03:46:21Z,98-20427,0,0,090000648056e598
FDA-1976-N-0027-0005,FDA,FDA-1976-N-0027,"Notice of Final Rule re Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the- Counter Human Use; Amendment of Monograph for OTC Nasal Decongestant Drug
Products",Notice,Notice of Final Rule,1998-07-31T04:00:00Z,1998,7,,,2015-10-29T19:26:46Z,,0,0,090000648051b690
FDA-1997-N-0069-0002,FDA,FDA-1997-N-0069,FDA,Notice,NWL-Notice of Withdrawl,1998-07-31T04:00:00Z,1998,7,,,2008-05-16T22:01:20Z,,0,0,09000064805d054a
FDA-1998-N-0103-0002,FDA,FDA-1998-N-0103,FDA,Notice,N-Notice,1998-07-31T04:00:00Z,1998,7,,,2008-05-16T21:37:59Z,,0,0,0900006480587503
FDA-1998-N-0103-0001,FDA,FDA-1998-N-0103,FDA,Notice,NM-Notice of Meeting,1998-07-31T04:00:00Z,1998,7,1998-07-31T04:00:00Z,1998-09-12T03:59:59Z,2008-05-16T21:37:58Z,,0,0,090000648058749a
FDA-1997-N-0010-0002,FDA,FDA-1997-N-0010,Hematopoietic Stem/Progenitor Cell Products: Discussion of Unrelated AflogeneicPlacental/Umbilical Cord Blood and Peripheral Blood Cell Banking and Transplantation; Notice of Public Workshop,Notice,NM-Notice of Meeting,1998-07-31T04:00:00Z,1998,7,,,2008-11-26T03:37:19Z,,0,0,09000064805c9a4f
FDA-1998-D-0101-0001,FDA,FDA-1998-D-0101,FDA,Notice,NAD-Notice of Availability of Data,1998-07-20T04:00:00Z,1998,7,1998-07-20T04:00:00Z,1998-10-14T03:59:59Z,2008-05-16T21:23:23Z,,0,0,09000064805871c3
FDA-1994-N-0036-0001,FDA,FDA-1994-N-0036,FDA,Notice,NFR-Notice of Final Rule,1998-07-06T04:00:00Z,1998,7,1998-07-06T04:00:00Z,1998-07-31T03:59:59Z,2008-05-16T23:15:35Z,,0,0,09000064804fd6ba
FDA-1998-N-0106-0001,FDA,FDA-1998-N-0106,FDA,Notice,NIR-Notice of Interim Rule,1998-06-30T04:00:00Z,1998,6,1998-06-30T04:00:00Z,1998-09-09T03:59:59Z,2008-05-16T21:38:08Z,,0,0,0900006480587cc3
FDA-1998-N-0006-0001,FDA,FDA-1998-N-0006,Administrative Practices and Procedures; Internal Agency Review of Decisions; Companion Document to Direct Final Rule,Notice,General Notice,1998-06-25T04:00:00Z,1998,6,1998-06-25T04:00:00Z,1998-09-01T03:59:59Z,2025-02-25T18:16:51Z,98-15814,0,0,0900006480558a26
FDA-1998-N-0006-0002,FDA,FDA-1998-N-0006,Administrative Practices and Procedures; Internal Review of Agency Decisions,Notice,Notice of Final Rule,1998-06-25T04:00:00Z,1998,6,1998-06-25T04:00:00Z,1998-09-01T03:59:59Z,2025-02-25T19:05:13Z,98-,0,0,0900006480558a65
FDA-1998-D-0052-0001,FDA,FDA-1998-D-0052,FDA,Notice,NAD-Notice of Availability of Data,1998-06-23T04:00:00Z,1998,6,1998-06-23T04:00:00Z,1998-08-27T03:59:59Z,2008-05-16T21:23:07Z,,0,0,090000648056e961
FDA-1998-D-0102-0001,FDA,FDA-1998-D-0102,FDA,Notice,NAD-Notice of Availability of Data,1998-06-12T04:00:00Z,1998,6,,,2008-05-16T21:23:24Z,,0,0,0900006480587328
FDA-1998-D-0098-0001,FDA,FDA-1998-D-0098,FDA,Notice,NAD-Notice of Availability of Data,1998-06-09T04:00:00Z,1998,6,1998-06-09T04:00:00Z,1998-09-10T03:59:59Z,2008-05-16T21:23:17Z,,0,0,0900006480586c2e
FDA-1998-D-0095-0001,FDA,FDA-1998-D-0095,FDA,Notice,NAD-Notice of Availability of Data,1998-06-05T04:00:00Z,1998,6,1998-06-05T04:00:00Z,1998-08-01T03:59:59Z,2008-05-16T21:23:14Z,,0,0,0900006480586845
FDA-1997-D-0027-0002,FDA,FDA-1997-D-0027,FDA,Notice,NAD-Notice of Availability of Data,1998-05-20T04:00:00Z,1998,5,,,2008-05-16T21:59:18Z,,0,0,09000064805ca339
FDA-1998-N-0105-0001,FDA,FDA-1998-N-0105,FDA,Notice,N-Notice,1998-05-19T04:00:00Z,1998,5,,,2008-05-16T21:38:06Z,,0,0,0900006480587b38
FDA-1998-N-0107-0001,FDA,FDA-1998-N-0107,Medical Devices; 30-Day Notices and 135-Day PMA Supplement Review,Notice,Notice of Final Rule,1998-05-05T04:00:00Z,1998,5,1998-05-05T04:00:00Z,1998-07-14T03:59:59Z,2026-02-07T03:28:03Z,98-11086,0,0,0900006480587e9f
FDA-1975-N-0013-0001,FDA,FDA-1975-N-0013,Status of Certain Additional Over-the-Counter Drug Category II and III Active Ingredients,Notice,Notice of Final Rule,1998-04-22T04:00:00Z,1998,4,,,2017-11-16T02:02:43Z,98–10578,0,0,09000064805c1d3c
FDA-1987-F-0031-0001,FDA,FDA-1987-F-0031,McNeil Specialty Products Co.,Notice,NFR-Notice of Final Rule,1998-04-10T04:00:00Z,1998,4,1998-04-10T04:00:00Z,1998-05-05T03:59:59Z,2008-05-30T22:53:26Z,,0,0,090000648046c473
FDA-1993-C-0016-0001,FDA,FDA-1993-C-0016,Listing of Color Additives Exempt from Certification; Canthaxanthin,Notice,Notice of Final Rule,1998-04-08T04:00:00Z,1998,4,1998-04-08T04:00:00Z,1998-04-28T03:59:59Z,2024-04-25T17:40:41Z,98-8127,0,0,09000064804fa6ef
FDA-1996-P-0309-0010,FDA,FDA-1996-P-0309,Food Labeling; Serving Sizes; Reference Amounts for Candies; Extension of Comment Period,Notice,Extension of Comment Period,1998-03-26T05:00:00Z,1998,3,2014-02-20T05:00:00Z,1998-05-27T03:59:59Z,2014-02-21T02:01:24Z,,0,0,0900006480504c84
FDA-1993-N-0043-0007,FDA,FDA-1993-N-0043,Expedited Safety Reporting Requirements for Human Drug and Biological Products; Correction,Notice,Correction,1998-03-26T05:00:00Z,1998,3,,,2024-04-29T15:00:31Z,,0,0,09000064804fc45a
FDA-1996-P-0246-0010,FDA,FDA-1996-P-0246,Food Labeling; Serving Sizes; Reference Amounts for Candies; Extension Comment Period,Notice,Notice of Extension,1998-03-25T05:00:00Z,1998,3,2014-02-20T05:00:00Z,1998-05-27T03:59:59Z,2014-02-21T02:01:52Z,,0,0,090000648050397a
FDA-1998-F-0072-0001,FDA,FDA-1998-F-0072,Edward S. Josephson,Notice,NFL-Notice of Filing,1998-03-24T05:00:00Z,1998,3,,,2008-05-16T21:24:40Z,,0,0,0900006480583c06
FDA-1996-P-0016-0003,FDA,FDA-1996-P-0016,HFS-165,Notice,NEC-Notice of Extension,1998-03-20T05:00:00Z,1998,3,1998-03-20T05:00:00Z,1998-05-20T03:59:59Z,2008-05-16T22:19:36Z,,0,0,09000064804fa0e0
FDA-1998-N-0069-0001,FDA,FDA-1998-N-0069,HFY-20,Notice,N-Notice,1998-03-20T05:00:00Z,1998,3,1998-03-20T05:00:00Z,1998-04-18T03:59:59Z,2008-05-16T21:31:28Z,,0,0,0900006480571d6b
FDA-1998-N-0068-0001,FDA,FDA-1998-N-0068,FDA,Notice,NM-Notice of Meeting,1998-03-05T05:00:00Z,1998,3,1998-03-05T05:00:00Z,1998-03-05T04:59:59Z,2008-05-16T21:31:26Z,,0,0,0900006480571cef
FDA-1996-D-0010-0002,FDA,FDA-1996-D-0010,FDA,Notice,NAD-Notice of Availability of Data,1998-02-27T05:00:00Z,1998,2,,,2008-05-16T22:15:19Z,,0,0,09000064804f9b2b
FDA-1998-D-0039-0001,FDA,FDA-1998-D-0039,FDA,Notice,NAD-Notice of Availability of Data,1998-02-27T05:00:00Z,1998,2,1998-02-27T05:00:00Z,1998-05-27T03:59:59Z,2008-05-16T21:23:02Z,,0,0,090000648056e4ed
FDA-1988-P-0024-0002,FDA,FDA-1988-P-0024,FDA,Notice,NFR-Notice of Final Rule,1998-02-23T05:00:00Z,1998,2,,,2008-05-30T22:52:53Z,,0,0,0900006480476376
FDA-1984-N-0021-0001,FDA,FDA-1984-N-0021,FDA,Notice,NAD-Notice of Availability of Data,1998-02-06T05:00:00Z,1998,2,,,2008-05-30T22:53:05Z,,0,0,09000064805a803a
FDA-1995-M-0032-0001,FDA,FDA-1995-M-0032,"Datascope Corp., Premarket Approval of the VasoSeal Vascular Hemostasis Device",Notice,Notice of Approval,1998-01-29T05:00:00Z,1998,1,1998-01-29T05:00:00Z,1996-01-16T04:59:59Z,2024-07-01T18:24:02Z,,0,0,090000648055ac8b
FDA-1990-N-0002-0011,FDA,FDA-1990-N-0002,FDA,Notice,NM-Notice of Meeting,1998-01-28T05:00:00Z,1998,1,,,2008-05-16T23:46:14Z,,0,0,0900006480525847
FDA-1997-N-0010-0001,FDA,FDA-1997-N-0010,Request for Proposed Standards for Unrelated Allogeneic Peripheral and Placental/Umbilical Cord Blood Hematopoietic Stem/Progenitor Cell Products; Request for Comments,Notice,N-Notice,1998-01-27T05:00:00Z,1998,1,,,2008-11-26T03:32:37Z,,0,0,09000064805c9a4b
FDA-1997-P-0065-0001,FDA,FDA-1997-P-0065,"Administrative Proceeding; Re: Pharmanex, Inc.",Notice,N-Notice,1998-01-16T05:00:00Z,1998,1,1998-01-16T05:00:00Z,1998-01-31T04:59:59Z,2009-01-08T01:42:41Z,,0,0,09000064805d035f
FDA-1997-D-0009-0001,FDA,FDA-1997-D-0009,FDA,Notice,NAD-Notice of Availability of Data,1998-01-16T05:00:00Z,1998,1,1998-01-16T05:00:00Z,1998-04-14T03:59:59Z,2008-05-16T21:59:17Z,,0,0,09000064805c9a34
FDA-1997-M-0061-0001,FDA,FDA-1997-M-0061,"Tab C: Vitreon Labeling re: Vitrophage, Inc.; Premarket Approval of VITREON",Notice,Notice of Approval,1998-01-14T05:00:00Z,1998,1,1998-01-14T05:00:00Z,1998-02-03T04:59:59Z,2024-12-02T14:08:29Z,,0,0,09000064805d030e
FDA-1997-M-0061-0003,FDA,FDA-1997-M-0061,"Tab A: Order re: Vitrophage, Inc.; Premarket Approval of VITREON",Notice,Notice of Approval,1998-01-14T05:00:00Z,1998,1,1998-01-14T05:00:00Z,1998-02-03T04:59:59Z,2024-12-02T14:11:06Z,,0,0,09000064805d0312
FDA-1997-M-0061-0004,FDA,FDA-1997-M-0061,"Vitrophage, Inc.; Premarket Approval of VITREON",Notice,Notice of Approval,1998-01-14T05:00:00Z,1998,1,1998-01-14T05:00:00Z,1998-02-03T04:59:59Z,2024-12-02T14:04:55Z,97-34157,0,0,09000064805d0313
FDA-1997-M-0061-0002,FDA,FDA-1997-M-0061,"Tab B: Summary of Safety and Effectiveness Data re: Vitrophage, Inc.; Premarket Approval of VITREON",Notice,Notice of Approval,1998-01-14T05:00:00Z,1998,1,1998-01-14T05:00:00Z,1998-02-03T04:59:59Z,2024-12-02T14:09:39Z,,0,0,09000064805d0310
FDA-1997-D-0056-0001,FDA,FDA-1997-D-0056,Iron-Containing Supplements and Drugs: Label Warning Statements and Unit-Dose Packaging Requirements; Small Entity Compliance Guide; Availability,Notice,Notice of Data Availability,1998-01-06T05:00:00Z,1998,1,,,2024-01-30T19:40:05Z,97-32552,0,0,09000064805cfd30
FDA-1997-N-0069-0001,FDA,FDA-1997-N-0069,FDA,Notice,NPR-Notice of Proposed Rule-Making,1998-01-06T05:00:00Z,1998,1,1998-01-06T05:00:00Z,1998-02-11T04:59:59Z,2008-05-16T22:01:20Z,,0,0,09000064805d04fa
FDA-1990-P-0023-0002,FDA,FDA-1990-P-0023,FDA,Notice,N-Notice,1998-01-02T05:00:00Z,1998,1,1998-01-02T05:00:00Z,1998-02-14T04:59:59Z,2008-05-16T23:50:52Z,,0,0,09000064805293bb
FDA-1996-P-0016-0002,FDA,FDA-1996-P-0016,FDA,Notice,NAP-Advanced Notice of Proposed Rulemaking,1998-01-02T05:00:00Z,1998,1,1998-01-02T05:00:00Z,1998-03-17T04:59:59Z,2008-05-16T22:19:43Z,,0,0,09000064804fa09c